At this time, posts about Hanmi Pharm are rapidly increasing on portals and securities communities. Today, foreigners have net sold 5,000 shares of Hanmi Pharm, and institutions have net sold 3,000 shares, according to provisional data. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.


As of 1:30 PM on the 4th, Hanmi Pharm's stock price is 352,000 KRW, down 3.96% from the previous day, with a trading volume of 120,633 shares, which is 89.76% of the 5-day average trading volume. On December 30th, Hanmi Pharm was a market topic due to "strength on expectations of COVID-19 vaccine contract manufacturing."


In addition to Hanmi Pharm, posts by investors are also rapidly increasing regarding Pobis T&C (016670), Hankook Franze (010100), and Daewoong Pharmaceutical (069620).


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing